Evidence map›Paper›PMID 42222075›Full record

ArticleFrontiers in endocrinology2026

Novel cardiac abnormalities observed in CAH patients with tenascin-X haploinsufficiency.

Andrea Sappl, Annie M Sriramachandran, Christian Lottspeich, Katharina Vill, Monika Morak, Ann-Christin Welp, Orsela Dervishi, Martin Bidlingmaier, Sonja Kunz, Nicole Reisch

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Andrea SapplMedizinische Klinik IV, LMU Klinikum, Ludwig-Maximilians-Universität München, Munich, Germany.
Annie M SriramachandranMedizinische Klinik IV, LMU Klinikum, Ludwig-Maximilians-Universität München, Munich, Germany.
Christian LottspeichMedizinische Klinik IV, LMU Klinikum, Ludwig-Maximilians-Universität München, Munich, Germany.
Katharina VillMedizinische Klinik IV, LMU Klinikum, Ludwig-Maximilians-Universität München, Munich, Germany.
Monika MorakMedizinische Klinik IV, LMU Klinikum, Ludwig-Maximilians-Universität München, Munich, Germany.
Ann-Christin WelpMedizinische Klinik IV, LMU Klinikum, Ludwig-Maximilians-Universität München, Munich, Germany.
Orsela DervishiMedizinische Klinik IV, LMU Klinikum, Ludwig-Maximilians-Universität München, Munich, Germany.
Martin BidlingmaierMedizinische Klinik IV, LMU Klinikum, Ludwig-Maximilians-Universität München, Munich, Germany.
Sonja KunzMedizinische Klinik IV, LMU Klinikum, Ludwig-Maximilians-Universität München, Munich, Germany.
Nicole ReischMedizinische Klinik IV, LMU Klinikum, Ludwig-Maximilians-Universität München, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Defects in both Objective: This study aimed to determine the frequency of CAH-X within the Munich cohort of CAH patients ( Design/setup: PCR screening for the presence of disease-causing variants in Outcome/conclusion: In our cohort, only 5% carry the CAH-X CH1 chimera. Besides EDS-related clinical symptoms, increased muscle echogenicity compared to unaffected matched controls, particularly in the legs, and cardiac abnormalities that have not been observed in other cohorts and are associated with underlying CAH-X, such as persistent truncus arteriosus and relaxation disorder, were observed. They highlight the importance of genetic as well as clinical screening and regular follow-up examinations for the CAH-X syndrome.

Indexed as

Adrenal Hyperplasia, CongenitalEhlers-Danlos SyndromeHaploinsufficiencyHeart Defects, CongenitalTenascinAdolescentAdultChildChild, PreschoolFemaleHumansMaleMutationSteroid 21-HydroxylaseYoung AdultCYP21A2 protein, humanSteroid 21-HydroxylaseTenascintenascin XCAH-X syndromechimeric TNXA/TNXB genecongenital adrenal hyperplasiaEhlers-Danlos syndrometenascin X haploinsufficiency

Identifiers

PMID42222075
PMCPMC13218977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.